Market Overview:
The global anal cancer therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of anal cancer, rising awareness about anal cancer and its treatment options, and technological advancements in the field of anal cancer therapeutics. Based on type, the global anal cancer therapeutics market is segmented into fluorouracil, cisplatin, and carboplatin. Of these, fluorouracil is expected to account for the largest share of the global market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030.
Product Definition:
Anal cancer therapeutics are treatments used to cure anal cancer. The most common type of anal cancer is squamous cell carcinoma, which is treated with surgery, radiation therapy, and chemotherapy.
Fluorouracil:
Fluorouracil, also known as 4- fluorouracil, is a cytotoxic drug with anti-cancer properties. It's mechanism of action involves the inhibition of DNA synthesis and RNA transcription. Fluorouracil has been found to be an effective treatment for various types of cancer such as skin, bladder, cervix and prostate cancer among others.
Cisplatin:
Cisplatin is a platinum-based chemotherapy drug. It was first synthesized in 1960 and approved by the FDA for use as an anti-cancer agent in 1970.
Application Insights:
The global market is segmented by application into hospitals, long-term care centers, pharmacies and diagnostic laboratories. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at a global level. Moreover, an increase in the prevalence of cancer across the globe has led to increased demand for treatment resulting in growth of this segment during recent years.
In 2017, long-term care centers were estimated to be fastest growing application with a CAGR 5.9% over forecast period due to increasing number of patients suffering from chronic diseases such as cancer requiring longer course of treatment and medication which drives growth within this segment during future years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of effective treatment methods for advanced cancers. In addition, increasing healthcare expenditure by governments and rising awareness about cancer screening are some other factors contributing to this dominance.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure in emerging countries such as China and India along with growing patient awareness levels regarding early diagnosis of cancer types such as anal canal carcinoma. Moreover, government initiatives for raising funds for research activities are also anticipated to boost regional growth during the forecast period (2018-2030).
Growth Factors:
- Increasing incidence of anal cancer
- Rising demand for better and more effective therapies for anal cancer
- Growing awareness about anal cancer and its treatment options
- Technological advancements in the field of anal cancer therapeutics
- increasing investment in research and development of new drugs for the treatment of anal cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Anal Cancer Therapeutics Market Research Report
By Type
Fluorouracil, Cisplatin, Carboplatin
By Application
Hospitals, Long-Term Care Centers, Pharmacies, Diagnostic Laboratories
By Companies
GlaxoSmithKline Pharmaceuticals, Spectrum Pharmaceuticals, Hospira, Global BioPharma, Advaxis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
198
Number of Tables & Figures
139
Customization Available
Yes, the report can be customized as per your need.
Global Anal Cancer Therapeutics Market Report Segments:
The global Anal Cancer Therapeutics market is segmented on the basis of:
Types
Fluorouracil, Cisplatin, Carboplatin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Long-Term Care Centers, Pharmacies, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline Pharmaceuticals
- Spectrum Pharmaceuticals
- Hospira
- Global BioPharma
- Advaxis
Highlights of The Anal Cancer Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorouracil
- Cisplatin
- Carboplatin
- By Application:
- Hospitals
- Long-Term Care Centers
- Pharmacies
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anal Cancer Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anal cancer therapies are treatments that are used to treat anal cancer. These treatments can include surgery, chemotherapy, and radiation therapy.
Some of the major companies in the anal cancer therapeutics market are GlaxoSmithKline Pharmaceuticals, Spectrum Pharmaceuticals, Hospira, Global BioPharma, Advaxis.
The anal cancer therapeutics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anal Cancer Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anal Cancer Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anal Cancer Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anal Cancer Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anal Cancer Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Anal Cancer Therapeutics Market Size and Y-o-Y Growth
4.5.2 Anal Cancer Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Anal Cancer Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anal Cancer Therapeutics Market Size Forecast by Type
5.2.1 Fluorouracil
5.2.2 Cisplatin
5.2.3 Carboplatin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anal Cancer Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anal Cancer Therapeutics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Long-Term Care Centers
6.2.3 Pharmacies
6.2.4 Diagnostic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anal Cancer Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anal Cancer Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anal Cancer Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Anal Cancer Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anal Cancer Therapeutics Market Size Forecast by Type
9.6.1 Fluorouracil
9.6.2 Cisplatin
9.6.3 Carboplatin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anal Cancer Therapeutics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Long-Term Care Centers
9.10.3 Pharmacies
9.10.4 Diagnostic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anal Cancer Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Anal Cancer Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anal Cancer Therapeutics Market Size Forecast by Type
10.6.1 Fluorouracil
10.6.2 Cisplatin
10.6.3 Carboplatin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anal Cancer Therapeutics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Long-Term Care Centers
10.10.3 Pharmacies
10.10.4 Diagnostic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anal Cancer Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anal Cancer Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anal Cancer Therapeutics Market Size Forecast by Type
11.6.1 Fluorouracil
11.6.2 Cisplatin
11.6.3 Carboplatin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anal Cancer Therapeutics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Long-Term Care Centers
11.10.3 Pharmacies
11.10.4 Diagnostic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anal Cancer Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Anal Cancer Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anal Cancer Therapeutics Market Size Forecast by Type
12.6.1 Fluorouracil
12.6.2 Cisplatin
12.6.3 Carboplatin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anal Cancer Therapeutics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Long-Term Care Centers
12.10.3 Pharmacies
12.10.4 Diagnostic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anal Cancer Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anal Cancer Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anal Cancer Therapeutics Market Size Forecast by Type
13.6.1 Fluorouracil
13.6.2 Cisplatin
13.6.3 Carboplatin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anal Cancer Therapeutics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Long-Term Care Centers
13.10.3 Pharmacies
13.10.4 Diagnostic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anal Cancer Therapeutics Market: Competitive Dashboard
14.2 Global Anal Cancer Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline Pharmaceuticals
14.3.2 Spectrum Pharmaceuticals
14.3.3 Hospira
14.3.4 Global BioPharma
14.3.5 Advaxis
